Product Description
Ursodeoxycholic acid (UDCA), also known as ursodiol, is anaturally-occurring bile acid that constitutes a minor fraction of the humanbile acid pool. UDCA has been used to treat liver disease for many years. UDCAwas first characterized in the bile and is formed by 7b-epimerization ofchenodeoxycholic acid, which is a primary bile acid. Due to its hydrophilicity,UDCA is less toxic than cholic acid or chenodeoxycholic acid.
Synonyms: Ursodiol,UDCA, 3-alpha,7-beta-Dioxycholanic acid, 7-beta-Hydroxylithocholic acid
Empirical Formula: C24H40O4
CAS Number: 128-13-2
Molecular Weight: 392.57
Critical Role in Liver Disease ManagementUrsodeoxycholic acid plays a vital role in managing liver diseases, such as cholestasis and certain liver cirrhosis cases. Its unique hydrophilic properties allow for effective reduction of toxic bile acids in the liver, improving liver function and patient outcomes. With ongoing medical research, UDCAs applications continue to benefit more patients.
Quality and Purity AssuranceAs a medicine-grade product, UDCA offered by top Indian distributors is guaranteed to have 100% purity, ensuring consistent therapeutic efficacy. The powders free-flowing, off white appearance indicates meticulous manufacturing standards. Adherence to CAS No: 128-13-2 and HS Code: 29163990 ensures compliance for import, export, and supply.
FAQs of Ursodeoxycholic acid:
Q: How is ursodeoxycholic acid used in the treatment of liver diseases?
A: Ursodeoxycholic acid is primarily prescribed to treat conditions like cholestasis and certain types of chronic liver diseases. It helps to modify the composition of bile, making it less toxic and promoting its excretion, which alleviates the strain on the liver.
Q: What are the main benefits of using UDCA compared to other bile acids?
A: UDCA is significantly less toxic than cholic acid or chenodeoxycholic acid due to its hydrophilic nature. This reduces potential side effects and makes it a safer option for long-term therapy in liver conditions.
Q: What is the physical appearance and form of ursodeoxycholic acid supplied by manufacturers?
A: Manufacturers provide ursodeoxycholic acid as an off white, free-flowing powder. This ensures ease of handling and accurate dosing in medicinal formulations.
Q: When should UDCA therapy be considered for liver disease patients?
A: UDCA therapy is generally recommended when patients are diagnosed with liver dysfunctions, such as cholestatic disorders, or have elevated toxic bile acids. Physicians assess individual cases to determine the appropriateness of its use.
Q: Who are the key suppliers and distributors of ursodeoxycholic acid in India?
A: In India, ursodeoxycholic acid is distributed, exported, imported, and manufactured by certified suppliers, traders, and pharmaceutical companies specializing in medicine-grade API.
Q: What is the process for obtaining UDCA for medicinal use?
A: UDCA can be sourced through licensed pharmaceutical suppliers or distributors. It is important to ensure that the product complies with CAS No: 128-13-2 and is medicine grade for safety and efficacy.